skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 21,911  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Alum adjuvant: some of the tricks of the oldest adjuvant
Material Type:
Article
Add to My Research

Alum adjuvant: some of the tricks of the oldest adjuvant

Journal of medical microbiology, 2012-07, Vol.61 (Pt 7), p.927-934 [Peer Reviewed Journal]

ISSN: 0022-2615 ;EISSN: 1473-5644 ;DOI: 10.1099/jmm.0.038943-0 ;PMID: 22174375

Full text available

2
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Material Type:
Article
Add to My Research

Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults

The New England journal of medicine, 2023-02, Vol.388 (7), p.595-608 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209604 ;PMID: 36791160

Full text available

3
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
Material Type:
Article
Add to My Research

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-08, Vol.389 (6), p.491-503 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302983 ;PMID: 37272513

Full text available

4
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Material Type:
Article
Add to My Research

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2780-2788 [Peer Reviewed Journal]

2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.3377 ;PMID: 26014293

Full text available

5
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine
Material Type:
Article
Add to My Research

Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine

New England Journal of Medicine, 2022-06, Vol.386 (22), p.2084-2096 [Peer Reviewed Journal]

Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2201300 ;PMID: 35507508

Digital Resources/Online E-Resources

6
Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses
Material Type:
Article
Add to My Research

Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responses

Nature communications, 2021-07, Vol.12 (1), p.4299-4299, Article 4299 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-24604-9 ;PMID: 34262038

Full text available

7
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation
Material Type:
Article
Add to My Research

pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation

Proceedings of the National Academy of Sciences - PNAS, 2016-07, Vol.113 (29), p.8098-8103 [Peer Reviewed Journal]

Volumes 1–89 and 106–113, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Jul 19, 2016 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1600816113 ;PMID: 27382168

Full text available

8
Adjuvants: Classification, Modus Operandi, and Licensing
Material Type:
Article
Add to My Research

Adjuvants: Classification, Modus Operandi, and Licensing

Journal of immunology research, 2016-01, Vol.2016, p.1459394-16 [Peer Reviewed Journal]

Copyright © 2016 Juliana de Souza Apostólico et al. ;Copyright © 2016 Juliana de Souza Apostolico et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2016 Juliana de Souza Apostólico et al. 2016 ;ISSN: 2314-8861 ;EISSN: 2314-7156 ;DOI: 10.1155/2016/1459394 ;PMID: 27274998

Full text available

9
The perfect mix: recent progress in adjuvant research
Material Type:
Article
Add to My Research

The perfect mix: recent progress in adjuvant research

Nature reviews. Microbiology, 2007-07, Vol.5 (7), p.505-397 [Peer Reviewed Journal]

Copyright Nature Publishing Group Jul 2007 ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/nrmicro1681 ;PMID: 17558426

Full text available

10
TLR-based immune adjuvants
Material Type:
Article
Add to My Research

TLR-based immune adjuvants

Vaccine, 2011-04, Vol.29 (17), p.3341-3355 [Peer Reviewed Journal]

2010 ;Published by Elsevier Ltd. ;Copyright Elsevier Limited Apr 12, 2011 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2010.08.002 ;PMID: 20713100

Full text available

11
New generation adjuvants – From empiricism to rational design
Material Type:
Article
Add to My Research

New generation adjuvants – From empiricism to rational design

Vaccine, 2015-06, Vol.33, p.B14-B20 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 8, 2015 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.01.088 ;PMID: 26022561

Full text available

12
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
Material Type:
Article
Add to My Research

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

Blood, 2002-11, Vol.100 (9), p.3063-3067 [Peer Reviewed Journal]

2002 American Society of Hematology ;2003 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2002-03-0996 ;PMID: 12384400

Full text available

13
CpG DNA as a vaccine adjuvant
Material Type:
Article
Add to My Research

CpG DNA as a vaccine adjuvant

Expert review of vaccines, 2011-04, Vol.10 (4), p.499-511 [Peer Reviewed Journal]

Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.10.174 ;PMID: 21506647

Full text available

14
Sedimentation behavior of quality and freeze-damaged aluminum-adjuvanted vaccines by w NMR
Material Type:
Article
Add to My Research

Sedimentation behavior of quality and freeze-damaged aluminum-adjuvanted vaccines by w NMR

Human vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2215152 [Peer Reviewed Journal]

ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2215152 ;PMID: 37254504

Full text available

15
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials
Material Type:
Article
Add to My Research

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials

JAMA, 2020-09, Vol.324 (10), p.951 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.15543

Digital Resources/Online E-Resources

16
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review
Material Type:
Article
Add to My Research

Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review

BMJ (Online), 2018-10, Vol.363, p.k3845 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k3845 ;PMID: 30297439

Full text available

17
Molecular identification of a danger signal that alerts the immune system to dying cells
Material Type:
Article
Add to My Research

Molecular identification of a danger signal that alerts the immune system to dying cells

Nature, 2003-10, Vol.425 (6957), p.516-521 [Peer Reviewed Journal]

COPYRIGHT 2003 Nature Publishing Group ;Copyright Macmillan Journals Ltd. Oct 2, 2003 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature01991 ;PMID: 14520412 ;CODEN: NATUAS

Full text available

18
Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles
Material Type:
Article
Add to My Research

Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles

Nucleic acids research, 2014-09, Vol.42 (15), p.9996-10004 [Peer Reviewed Journal]

The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. ;The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. 2014 ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gku516 ;PMID: 25092921

Full text available

19
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
Material Type:
Article
Add to My Research

Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy

The New England journal of medicine, 2016-11, Vol.375 (19), p.1845-1855 [Peer Reviewed Journal]

Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611299 ;PMID: 27717298

Full text available

20
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
Material Type:
Article
Add to My Research

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

The New England journal of medicine, 2018-05, Vol.378 (19), p.1789-1801 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;(c) Massachusetts Medical Society, 2018 info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1802357 ;PMID: 29658430

Full text available

Results 1 - 20 of 21,911  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (20,811)

Refine My Results

Creation Date 

From To
  1. Before 1964  (120)
  2. 1964 To 1978  (860)
  3. 1979 To 1993  (2,915)
  4. 1994 To 2009  (10,700)
  5. After 2009  (7,331)
  6. More options open sub menu

Language 

  1. English  (21,463)
  2. Japanese  (3,021)
  3. German  (145)
  4. French  (131)
  5. Spanish  (115)
  6. Portuguese  (99)
  7. Polish  (33)
  8. Russian  (25)
  9. Italian  (24)
  10. Chinese  (17)
  11. Swedish  (11)
  12. Norwegian  (8)
  13. Croatian  (3)
  14. Turkish  (2)
  15. Serbian  (1)
  16. Korean  (1)
  17. Dutch  (1)
  18. Ukrainian  (1)
  19. More options open sub menu

Searching Remote Databases, Please Wait